UC San Francisco Cell Therapy Raises Hope for Severe Human Forms
Epilepsy that does not respond to drugs can be halted in adult mice by transplanting a specific type of cell into the brain, UC San Francisco researchers have discovered, raising hope that a similar treatment might work in severe forms of human epilepsy.
UCSF scientists controlled seizures in epileptic mice with a one-time transplantation of medial ganglionic eminence (MGE) cells, which inhibit signaling in overactive nerve circuits, into the hippocampus, a brain region associated with seizures, as well as with learning and memory. Other researchers had previously used different cell types in rodent cell transplantation experiments and failed to stop seizures.
Cell therapy has become an active focus of epilepsy research, in part because current medications, even when effective, only control symptoms and not underlying causes of the disease, according to Scott C. Baraban, PhD, who holds the William K. Bowes Jr. Endowed Chair in Neuroscience Research at UCSF and led the new study. In many types of epilepsy, he said, current drugs have no therapeutic value at all.
“Our results are an encouraging step toward using inhibitory neurons for cell transplantation in adults with severe forms of epilepsy,” Baraban said. “This procedure offers the possibility of controlling seizures and rescuing cognitive deficits in these patients.”
The findings, which are the first ever to report stopping seizures in mouse models of adult human epilepsy, will be published online May 5 in the journal Nature Neuroscience.
During epileptic seizures, extreme muscle contractions and, often, a loss of consciousness can cause seizure sufferers to lose control, fall and sometimes be seriously injured. The unseen malfunction behind these effects is the abnormal firing of many excitatory nerve cells in the brain at the same time.
In the UCSF study, the transplanted inhibitory cells quenched this synchronous, nerve-signaling firestorm, eliminating seizures in half of the treated mice and dramatically reducing the number of spontaneous seizures in the rest. Robert Hunt, PhD, a postdoctoral fellow in the Baraban lab, guided many of the key experiments.
In another encouraging step, UCSF researchers reported May 2 that they found a way to reliably generate human MGE-like cells in the laboratory, and that, when transplanted into healthy mice,the cells similarly spun off functional inhibitory nerve cells. That research can be found online in the journal Cell Stem Cell.
In many forms of epilepsy, loss or malfunction of inhibitory nerve cells within the hippocampus plays a critical role. MGE cells are progenitor cells that form early within the embryo and are capable of generating mature inhibitory nerve cells called interneurons. In the Baraban-led UCSF study, the transplanted MGE cells from mouse embryos migrated and generated interneurons, in effect replacing the cells that fail in epilepsy. The new cells integrated into existing neural circuits in the mice, the researchers found.
“These cells migrate widely and integrate into the adult brain as new inhibitory neurons,” Baraban said. “This is the first report in a mouse model of adult epilepsy in which mice that already were having seizures stopped having seizures after treatment.”
The mouse model of disease that Baraban’s lab team worked with is meant to resemble a severe and typically drug-resistant form of human epilepsy called mesial temporal lobe epilepsy, in which seizures are thought to arise in the hippocampus. In contrast to transplants into the hippocampus, transplants into the amygdala, a brain region involved in memory and emotion, failed to halt seizure activity in this same mouse model, the researcher found.
The Latest Bing News on:
- FDA Grants First Conditional Approval Under Expanded Authority to Control Seizures in Dogs with Idiopathic Epilepsyon January 15, 2021 at 1:09 am
Today, the U.S. Food and Drug Administration granted the first conditional approval under its expanded authority to KBroVet-CA1 (potassium bromide chewable tablets) to control seizures in dogs with ...
- UCB Announces Launch of Nile AI, Inc., a Digital Health Company Set to Transform the Course of Epilepsyon January 13, 2021 at 10:53 pm
UCB today announced the launch of Nile AI, Inc., a new independent company created to improve care for people living with epilepsy, their caregivers, and healthcare providers (HCPs). Nile was founded ...
- Couple 'spend thousands' on medicinal cannabis for one-year-old with epilepsyon January 13, 2021 at 8:46 am
A couple from Frome whose daughter has severe epilepsy have spent thousands of pounds on medicinal cannabis because they cannot access it on the NHS. Emily Howis and Spencer Carkeet are now ...
- 'Have I been a bad mum?' Mothers reveal their 'guilt' after taking 'poisonous' epilepsy drug during pregnancy that left their children with issues such as deafness and autismon January 13, 2021 at 2:17 am
Viewers of Channel 4's Are Women the Fitter Sex? were left shocked last night after three British mothers discussed the impact an epilepsy drug taken during pregnancy had on their children.
- Camila Coelho On Trying To Get Pregnant With Epilepsy: ‘Sharing My Fears Was The Best Thing I’ve Done’on January 9, 2021 at 4:50 am
Camila Coelho opens up about living with the condition, and her decision to stay on her medication while pregnant.
- Four of 10 most common epilepsy medications increase risk of baby ‘having physical birth defect if taken while pregnant’on January 8, 2021 at 7:04 am
Past mistakes must not be repeated. We know that the consequences of women not knowing information such as this can be devastating,’ says campaigner ...
- Parents of children with severe epilepsy warn cannabis medication stopping after Brexiton January 7, 2021 at 5:16 am
Tannine Clarry, 32, from Suffolk, fears that losing access to the prescription will cost her six-year-old daughter Indie-Rose her independence and set back years of progress.
- Michael and Lisa Cotton fund epilepsy research projects in honor of daughter Vivianon January 6, 2021 at 4:00 am
Vivian lived 18 months as a 27-week premature baby before her parents, Michael and Lisa Cotton of Grosse Pointe Farms, watched as their daughter succumbed in April 2015 to multiple medical ...
- Kid-friendly epilepsy diagnosison January 4, 2021 at 2:03 pm
MEG helps to improve non-invasive patient diagnosis with less trauma, lower risk to the patient and better outcomes at a lower cost. ► Make it easy to keep up to date with more stories like this.
- Epilepsy Drugs Market 2021 CAGR Status, Industry Share, Growth by Top Companies, Growth Rate, Trends by Types and Application and Forecast to 2024on January 4, 2021 at 2:23 am
Epilepsy Drugs Market” is analysed by product types, applications and key market players for market size, sales (consumption), gross margin and revenue. The Epilepsy Drugs market share data is the ...
The Latest Google Headlines on:
The Latest Bing News on:
- Gracell Biotechnologies Receives Medical Products Manufacturing Certificate for CAR-T Cell Therapy Productson January 15, 2021 at 9:54 pm
PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for ...
- Cell therapy biotech Vor Biopharma files for a $150 million IPOon January 15, 2021 at 3:49 pm
V or Biopharma, a Phase 1/2 biotech developing cell therapies for hematological diseases, filed on Friday with the SEC to raise up to $150 million in an initial public offering. The company's pipeline ...
- Upcoming Clinical Trial Will Test New Cell Therapy for Parkinson’s Disease in Humanson January 15, 2021 at 2:11 pm
Study will be the first clinical trial testing an investigational stem cell therapy aimed at restoring lost brain cells called neurons in people with advanced Parkinson’s disease (PD).
- Global Cell Therapy Technologies Market Size, Historical Growth, Analysis, Opportunities and Forecast To 2025on January 15, 2021 at 12:38 pm
Selbyville, Delaware, MarketStudyReport.com added report on Global Cell Therapy Technologies Market that evaluates industry growth trends through historical data and estimates prospects based on ...
- Oncternal Therapeutics, Inc. Confirms Lentigen Technology, Inc. to Manufacture Lentiviral Vectors for Its ROR1-targeting CAR-T Cell Therapy Programon January 14, 2021 at 5:23 am
Lentigen is a leader in translating gene therapy products into the clinic, including design, construction and production of lentiviral vectors, from research through GMP manufacturing. As part of the ...
- Global Cell Therapy Market Size By End User, By Region 2021 | Overview, Growth, Economics, Demand And Forecast Research Report To 2026on January 13, 2021 at 3:29 pm
The report provides revenue of the global Cell Therapy market for the period 2016 and 2025, considering 2019 as the ...
- Hope for children with rare heart condition: novel stem cell therapy to save the dayon January 13, 2021 at 5:33 am
Researchers put forward a safe and efficient new stem cell therapy for regenerating cardiac function in pediatric patients.
- Cell therapy biotech Sana Biotechnology files for a $150 million IPOon January 13, 2021 at 5:13 am
S ana Biotechnology, a preclinical biotech developing engineered cell therapies for multiple indications, filed on Wednesday with the SEC to raise up to $150 million in an initial public offering.
- Propanc Biopharma Analyzes Pancreatic Proenzymes Vs T-Cell Therapy Targeting Solid Tumors Such as Pancreatic, Ovarian & Colorectal Cancerson January 11, 2021 at 5:30 am
Cell therapy has advanced the standard of cancer treatment, new approaches like proenzyme therapy may treat and prevent metastatic cancer.
- Adocia Files Patent on a Hydrogel Scaffold for Cell Therapy in the Treatment of Type 1 Diabeteson January 10, 2021 at 4:30 pm
Adocia has developed an innovative hydrogel to host and protect pancreatic cell implants This hydrogel scaffold containing pancreatic cells could restore glycemic control without requiring insulin ...